KayoThera: Funding, Investors & Team (Sep 2026)
KayoThera, a biotechnology firm based in Princeton, New Jersey, specializes in creating treatments to heal advanced and metastatic cancers. Their initiatives focus on blocking an important enzyme that shields cancer cells and reducing regulatory T-cells, aiming to provide potential cures for previously untreatable cancers and instill optimism in patients. The company's primary goal is to develop pioneering immunotherapies and targeted therapies to ultimately bring about cures for advanced cancer cases. Founded in 2019, KayoThera is headquartered in Princeton, New Jersey.
KayoThera has raised $13.2M across 2 funding rounds on record, the most recent a Series A of $5.2M announced in Jul 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
KayoThera Company Profile and Key Stats
Latest funding round on record: Jul 2023.
KayoThera Funding Rounds
KayoThera raised $8.0M in a Series A announced in Mar 2022.
1.3 years later, a Series A of $5.2M was announced in Jul 2023.
KayoThera Founders and Leadership Team
Contact details for the KayoThera team: 1 of 1 has an email address on file.
Start 14-day free trial →KayoThera Funding Compared to Other Biotechnology Startups
KayoThera's latest round of $5.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like KayoThera in Biotechnology and Princeton
Companies Similar to KayoThera
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
KayoThera Funding FAQs
What does KayoThera do?
KayoThera, a biotechnology firm based in Princeton, New Jersey, specializes in creating treatments to heal advanced and metastatic cancers. Their initiatives focus on blocking an important enzyme that shields cancer cells and reducing regulatory T-cells, aiming to provide potential cures for previously untreatable cancers and instill optimism in patients. The company's primary goal is to develop pioneering immunotherapies and targeted therapies to ultimately bring about cures for advanced cancer cases. Founded in 2019, KayoThera is headquartered in Princeton, New Jersey.
How much funding has KayoThera raised?
KayoThera has raised $13.2M across 2 rounds on record. The most recent is a Series A of $5.2M announced in Jul 2023.
When did KayoThera last raise funding?
KayoThera's most recent funding round on record is a Series A of $5.2M, announced in Jul 2023.
Who founded KayoThera?
FundedIQ lists Mark Esposito (Founder) at KayoThera.
Where is KayoThera headquartered?
KayoThera is based in Princeton, New Jersey, United States.
How many employees does KayoThera have?
KayoThera is in the 1-10 employee band.
How does KayoThera's funding compare to other Biotechnology startups?
KayoThera's latest round of $5.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's KayoThera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KayoThera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.